Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Consolidated Net Income (2009 - 2026)

Updated

Regeneron Pharmaceuticals (REGN) recorded Consolidated Net Income of $1.3 billion in Q2 2026, down 6.8% from $1.39 billion a year earlier but up 78.3% from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Consolidated Net Income (2009 - 2026) Analysis & Trends

On a TTM basis, Regeneron Pharmaceuticals' Consolidated Net Income came in at $4.33 billion as of Jun 30, 2026, down 2.9% year-over-year; for FY2025, it was $4.5 billion, up 2.1% from FY2024.

  • Annual Consolidated Net Income has a five-year compound annual growth rate of 5.1% (FY2020 to FY2025).
  • Across earlier years, Consolidated Net Income came in at $4.41 billion in FY2024 (+11.6%), $3.95 billion in FY2023 (-8.9%), $4.34 billion in FY2022 (-46.3%) and $8.08 billion in FY2021 (+129.9%).
  • Quarterly Consolidated Net Income has ranged from $722 million in Q1 2024 to $2.23 billion in Q4 2021 over the past five years.
  • On a year-over-year basis, Consolidated Net Income has declined for three consecutive quarters, with growth averaging 0.7% over the last eight quarters.
  • Peak year-over-year performance for Consolidated Net Income in the last five years was growth of 94.0% in Q4 2021, against a decline of 72.5% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $727.2 million (Q1 2026), $844.6 million (Q4 2025) and $1.46 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 5.53 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 3.62 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 2.51 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -10.50 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -237.00 Mn
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn 1.30 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.30 Bn
Mar 31, 2026 727.20 Mn
Dec 31, 2025 844.60 Mn
Sep 30, 2025 1.46 Bn
Jun 30, 2025 1.39 Bn
Mar 31, 2025 808.70 Mn
Dec 31, 2024 917.70 Mn
Sep 30, 2024 1.34 Bn
Jun 30, 2024 1.43 Bn
Mar 31, 2024 722.00 Mn
Dec 31, 2023 1.16 Bn
Sep 30, 2023 1.01 Bn
Jun 30, 2023 968.40 Mn
Mar 31, 2023 817.80 Mn
Dec 31, 2022 1.20 Bn
Sep 30, 2022 1.32 Bn
Jun 30, 2022 852.10 Mn
Mar 31, 2022 973.50 Mn
Dec 31, 2021 2.23 Bn
Sep 30, 2021 1.63 Bn
API Access

Regeneron Pharmaceuticals Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=REGN&period=max&api_key=YOUR_API_KEY